ArticleFrontiers in plant science2025
Comparative functional analyses of the movement and coat proteins of grapevine Pinot gris virus, encoded by symptomatic and asymptomatic variants.
Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Using small RNA high-throughput sequencing (HTS), we previously demonstrated the widespread distribution of grapevine Pinot gris virus (GPGV) in Hungarian vineyards. This trichovirus has been associated with a disease known as grapevine leaf mottling and deformation (GLMD). However, since GPGV has been detected in both symptomatic and asymptomatic plants, its exact role in GLMD disease is not well-characterised. Studies addressing this question suggested that differences in the GPGV susceptibility of the grapevine cultivars and the presence of variants of the virus could affect symptom development. Being able to suppress various steps of the RNA interference-based defence reactions, the viral suppressor of RNAi (VSR), encoded by the ORF3 of GPGV, can also alter the symptom development. In the present study, we compared the VSR activity of the ORF3-encoded coat protein of symptomatic and asymptomatic GPGV variants and found that both possess VSR activity. Testing the VSR activity of the ORF2-encoded movement proteins from the two variants, using a GFP-based transient gene expression assay, we found that the GPGV-MP has weak systemic VSR activity. Moreover, we found that the transient expression of the MP variants induced necrosis in the infiltrated leaves, which was stronger in the case of the symptomatic variant. To functionally characterise the crucial sequence elements of MP responsible for this difference in the necrosis between symptomatic and asymptomatic variants, the necrosis-inducing activity of GPGV-MP encoded by different natural and recombinant variants was tested. Differences in the GPGV-MP necrosis-inducing activity suggested that, besides the previously described C/T polymorphism, different phosphorylation patterns of the GPGV-MP may contribute to symptom development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.